Programme

Keywords
PDF version

Wed 23 Oct

10:00

e-poster session day 1

to
Digital kiosks
e-poster session

e-poster session day 1

to
Digital kiosks
e-poster session

11:50

Lives at risk: mental health and substance use

to
Auditorium VII
Oral presentation session

Prevalence of opioids and related harms

to
Auditorium VIII
Oral presentation session

Mechanisms and outcomes in substance use prevention among youth

to
Room 5A
Oral presentation session

Building addiction workforce capacity

to
Room 5C
Oral presentation session

14:20

Neuroscience and cognition

to
Auditorium III
Short communication session

Legal shifts and their Impact on drug use and sentencing

to
Auditorium IV
Oral presentation session

Drug policy and the criminal legal system

to
Auditorium VI
Oral presentation session

Methods and measurement

to
Room 1.08
Short communication session

16:00

The recovery journey

to
Auditorium III
Oral presentation session

Infectious diseases in people who inject drugs

to
Auditorium IV
Oral presentation session

Surveillance of drug-related morbidity and mortality

to
Room 5A
Oral presentation session

Conceptualising health and harms

to
Room 1.08
Short communication session

17:50

NPS: trends, concerns and response strategies

to
Auditorium III
Oral presentation session

Drug use trends

to
Auditorium IV
Oral presentation session

Decriminalisation and alternatives to arrest

to
Auditorium VI
Oral presentation session

Opioid treatment 1

to
Room 5B
Oral presentation session

Motivations for use

to
Room 5C
Oral presentation session

Hepatitis C, HIV, and other drug related harms

to
Room 1.05
Short communication session

Hepatitis C, HIV, and other drug related harms

to
Room 1.05
Short communication session

Opioids: trends, use and treatments

to
Room 1.06
Short communication session

Thu 24 Oct

11:50

Opioid treatment 2

to
Auditorium III
Oral presentation session

Opioid Agonist Treatment: novel formulations and challenges

to
Auditorium IV
Oral presentation session

Emerging drug harms, DCRs and other responses

to
Auditorium VII
Short communication session

Innovative methods for understanding drug markets and policy

to
Room 5A
Oral presentation session

Workers reaching marginalised groups

to
Room 5C
Oral presentation session

14:20

Novel neurobiology - cannabis, cognition and craving

to
Auditorium III
Oral presentation session

Understanding drug-related deaths

to
Auditorium IV
Oral presentation session

Pregnancy, drug use and care

to
Room 5B
Oral presentation session

Co-creating robust systems with workers

to
Room 5C
Oral presentation session

Understanding harm reduction: economic, social, and health perspectives

to
Room 1.05
Short communication session

Understanding harm reduction: economic, social, and health perspectives

to
Room 1.05
Short communication session

Women's realities of drug use

to
Room 1.08
Oral presentation session

16:00

NPS: Pharmacological Characterization and Substance Analysis

to
Auditorium III
Oral presentation session

Hepatitis C testing and treatment

to
Auditorium IV
Oral presentation session

How can treatment be a better experience?

to
Auditorium VII
Oral presentation session

The hepatitis C endgame: Science, Policy, Politics

to
Auditorium VIII
Major session

From genes to brains

to
Room 1.06
Short communication session

17:50

Viral hepatitis among people who inject drugs

to
Auditorium IV
Oral presentation session

Substance use and mental health in treatment settings

to
Auditorium VII
Oral presentation session

Misuse of medicines

to
Auditorium VIII
Oral presentation session

Hospital-based treatments

to
Room 5B
Oral presentation session

Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform

to
Room 1.06
Short communication session

Fri 25 Oct

11:50

The ripple effect: International developments in the opioid market and their potential implications for European public health and security

to
Auditorium I
Major session

Intentional and non-intentional drug-related deaths

to
Auditorium IV
Oral presentation session

Emerging challenges in drug markets: monitoring, measurement & impacts

to
Room 1.05
Short communication session

14:20

Overdose prevention

to
Auditorium IV
Oral presentation session

Addressing diverse treatment needs

to
Auditorium VI
Oral presentation session

Substance use and mental health in prison settings

to
Auditorium VII
Oral presentation session

Prevention and addiction in underrepresented groups

to
Room 5A
Oral presentation session

Impact of drug policy on drug production & markets

to
Room 5B
Oral presentation session

Holistic care for mental well-being

to
Room 1.05
Short communication session

Future of opioid markets in Europe: Foresight approaches

to
Room 1.10
Workshop